109 related articles for article (PubMed ID: 20691509)
1. QSAR study of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2 using LS-SVM and GRNN based on principal components.
Shahlaei M; Sabet R; Ziari MB; Moeinifard B; Fassihi A; Karbakhsh R
Eur J Med Chem; 2010 Oct; 45(10):4499-508. PubMed ID: 20691509
[TBL] [Abstract][Full Text] [Related]
2. Lead optimization of methionine aminopeptidase-2 (MetAP2) inhibitors containing sulfonamides of 5,6-disubstituted anthranilic acids.
Wang GT; Mantei RA; Kawai M; Tedrow JS; Barnes DM; Wang J; Zhang Q; Lou P; Garcia LA; Bouska J; Yates M; Park C; Judge RA; Lesniewski R; Sheppard GS; Bell RL
Bioorg Med Chem Lett; 2007 May; 17(10):2817-22. PubMed ID: 17350258
[TBL] [Abstract][Full Text] [Related]
3. Application of PC-ANN and PC-LS-SVM in QSAR of CCR1 antagonist compounds: a comparative study.
Shahlaei M; Fassihi A; Saghaie L
Eur J Med Chem; 2010 Apr; 45(4):1572-82. PubMed ID: 20170987
[TBL] [Abstract][Full Text] [Related]
4. Validated QSAR analysis of some diaryl substituted pyrazoles as CCR2 inhibitors by various linear and nonlinear multivariate chemometrics methods.
Arkan E; Shahlaei M; Pourhossein A; Fakhri K; Fassihi A
Eur J Med Chem; 2010 Aug; 45(8):3394-406. PubMed ID: 20493592
[TBL] [Abstract][Full Text] [Related]
5. The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.
Levin JI; Du MT; DiJoseph JF; Killar LM; Sung A; Walter T; Sharr MA; Roth CE; Moy FJ; Powers R; Jin G; Cowling R; Skotnicki JS
Bioorg Med Chem Lett; 2001 Jan; 11(2):235-8. PubMed ID: 11206467
[TBL] [Abstract][Full Text] [Related]
6. Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 1: Structure-based design of novel acetylenic P1' groups.
Chen JM; Jin G; Sung A; Levin JI
Bioorg Med Chem Lett; 2002 Apr; 12(8):1195-8. PubMed ID: 11934587
[TBL] [Abstract][Full Text] [Related]
7. Application of partial least squares and radial basis function neural networks in multivariate imaging analysis-quantitative structure activity relationship: study of cyclin dependent kinase 4 inhibitors.
Saghaie L; Shahlaei M; Madadkar-Sobhani A; Fassihi A
J Mol Graph Model; 2010 Dec; 29(4):518-28. PubMed ID: 21071247
[TBL] [Abstract][Full Text] [Related]
8. Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.
Levin JI; Chen JM; Du MT; Nelson FC; Killar LM; Skala S; Sung A; Jin G; Cowling R; Barone D; March CJ; Mohler KM; Black RA; Skotnicki JS
Bioorg Med Chem Lett; 2002 Apr; 12(8):1199-202. PubMed ID: 11934588
[TBL] [Abstract][Full Text] [Related]
9. Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding.
Sheppard GS; Wang J; Kawai M; Fidanze SD; BaMaung NY; Erickson SA; Barnes DM; Tedrow JS; Kolaczkowski L; Vasudevan A; Park DC; Wang GT; Sanders WJ; Mantei RA; Palazzo F; Tucker-Garcia L; Lou P; Zhang Q; Park CH; Kim KH; Petros A; Olejniczak E; Nettesheim D; Hajduk P; Henkin J; Lesniewski R; Davidsen SK; Bell RL
J Med Chem; 2006 Jun; 49(13):3832-49. PubMed ID: 16789740
[TBL] [Abstract][Full Text] [Related]
10. The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.
Levin JI; Chen J; Du M; Hogan M; Kincaid S; Nelson FC; Venkatesan AM; Wehr T; Zask A; DiJoseph J; Killar LM; Skala S; Sung A; Sharr M; Roth C; Jin G; Cowling R; Mohler KM; Black RA; March CJ; Skotnicki JS
Bioorg Med Chem Lett; 2001 Aug; 11(16):2189-92. PubMed ID: 11514167
[TBL] [Abstract][Full Text] [Related]
11. Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties.
Kawai M; BaMaung NY; Fidanze SD; Erickson SA; Tedrow JS; Sanders WJ; Vasudevan A; Park C; Hutchins C; Comess KM; Kalvin D; Wang J; Zhang Q; Lou P; Tucker-Garcia L; Bouska J; Bell RL; Lesniewski R; Henkin J; Sheppard GS
Bioorg Med Chem Lett; 2006 Jul; 16(13):3574-7. PubMed ID: 16632353
[TBL] [Abstract][Full Text] [Related]
12. Quantum chemical QSAR models to distinguish between inhibitory activities of sulfonamides against human carbonic anhydrases I and II and bovine IV isozymes.
Deeb O; Goodarzi M; Khadikar PV
Chem Biol Drug Des; 2012 Apr; 79(4):514-22. PubMed ID: 22181786
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR studies of some reversible Acetyl cholinesterase inhibitors based on CoMFA and ligand protein interaction fingerprints using PC-LS-SVM and PLS-LS-SVM.
Ghafouri H; Ranjbar M; Sakhteman A
Comput Biol Chem; 2017 Aug; 69():19-27. PubMed ID: 28544873
[TBL] [Abstract][Full Text] [Related]
14. Sulfoximine directed intermolecular o-C-H amidation of arenes with sulfonyl azides.
Yadav MR; Rit RK; Sahoo AK
Org Lett; 2013 Apr; 15(7):1638-41. PubMed ID: 23477353
[TBL] [Abstract][Full Text] [Related]
15. Structural Investigation for Optimization of Anthranilic Acid Derivatives as Partial FXR Agonists by in Silico Approaches.
Chen M; Yang X; Lai X; Kang J; Gan H; Gao Y
Int J Mol Sci; 2016 Apr; 17(4):536. PubMed ID: 27070594
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory activity of para-substituted N-benzenesulfonyl derivatives of anthranilic acid.
Borne RF; Peden RL; Waters IW; Weiner M; Jordan R; Coats EA
J Pharm Sci; 1974 Apr; 63(4):615-7. PubMed ID: 4828717
[No Abstract] [Full Text] [Related]
17. Synthesis and anti-inflammatory evaluation of N-sulfonyl anthranilic acids via Ir(III)-catalyzed C-H amidation of benzoic acids.
Han SH; Suh HS; Jo H; Oh Y; Mishra NK; Han S; Kim HS; Jung YH; Lee BM; Kim IS
Bioorg Med Chem Lett; 2017 May; 27(10):2129-2134. PubMed ID: 28389150
[TBL] [Abstract][Full Text] [Related]
18. QSAR models for 2-amino-6-arylsulfonylbenzonitriles and congeners HIV-1 reverse transcriptase inhibitors based on linear and nonlinear regression methods.
Hu R; Doucet JP; Delamar M; Zhang R
Eur J Med Chem; 2009 May; 44(5):2158-71. PubMed ID: 19054595
[TBL] [Abstract][Full Text] [Related]
19. Image-Based Analysis to Predict the Activity of Tariquidar Analogs as P-Glycoprotein Inhibitors: The Importance of External Validation.
Shayanfar S; Shayanfar A; Ghandadi M
Arch Pharm (Weinheim); 2016 Feb; 349(2):124-31. PubMed ID: 26708190
[TBL] [Abstract][Full Text] [Related]
20. QSAR models for predicting the toxicity of piperidine derivatives against Aedes aegypti.
Doucet JP; Papa E; Doucet-Panaye A; Devillers J
SAR QSAR Environ Res; 2017 Jun; 28(6):451-470. PubMed ID: 28604113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
